Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face
Clinical trial NCT00986570 · COMPLETED
Trial details
- NCT number
- NCT00986570
- Sponsor
- Biolab Sanus Farmaceutica
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-06-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.